Cargando…

Advances in the allostery of angiotensin II type 1 receptor

Angiotensin II type 1 receptor (AT1R) is a promising therapeutic target for cardiovascular diseases. Compared with orthosteric ligands, allosteric modulators attract considerable attention for drug development due to their unique advantages of high selectivity and safety. However, no allosteric modu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xi, Zhang, Suli, Wang, Meili, Chen, Hao, Liu, Huirong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276441/ https://www.ncbi.nlm.nih.gov/pubmed/37330563 http://dx.doi.org/10.1186/s13578-023-01063-x

Ejemplares similares

Large‐Conductance Calcium‐Activated Potassium Channel Opener, NS1619, Protects Against Mesenteric Artery Remodeling Induced by Agonistic Autoantibodies Against the Angiotensin II Type 1 Receptor
por: Wang, Meili, et al.
Publicado: (2022)

Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor
por: Wei, Mingming, et al.
Publicado: (2016)

The Prognostic Role of Angiotensin II Type 1 Receptor Autoantibody in Non-Gravid Hypertension and Pre-eclampsia: A Meta-analysis and Our Studies
por: Lei, Jinghui, et al.
Publicado: (2016)

Gi-protein-coupled β (1)-adrenergic receptor: re-understanding the selectivity of β (1)-adrenergic receptor to G protein : Gi-protein-coupled β (1)-adrenergic receptor
por: Chen, Hao, et al.
Publicado: (2022)

QR code model: a new possibility for GPCR phosphorylation recognition
por: Chen, Hao, et al.
Publicado: (2022)

Angiotensin II inhibits apoptosis of mouse aortic smooth muscle cells through regulating the circNRG-1/miR-193b-5p/NRG-1 axis
por: Sun, Yan, et al.
Publicado: (2019)

Autoantibodies against AT1 Receptor Contribute to Vascular Aging and Endothelial Cell Senescence
por: Wang, Meili, et al.
Publicado: (2019)

Toward an understanding of the structural basis of allostery in muscarinic acetylcholine receptors
por: Burger, Wessel A.C., et al.
Publicado: (2018)

Cryo‐EM reveals mechanisms of angiotensin I‐converting enzyme allostery and dimerization
por: Lubbe, Lizelle, et al.
Publicado: (2022)

HIV-1 Envelope Conformation, Allostery, and Dynamics
por: Bennett, Ashley Lauren, et al.
Publicado: (2021)

Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy
por: Ma, Ye-Ping, et al.
Publicado: (2020)

Allostery of atypical modulators at oligomeric G protein-coupled receptors
por: Shivnaraine, Rabindra V., et al.
Publicado: (2021)

Renal Denervation Influences Angiotensin II Types 1 and 2 Receptors
por: Hosseini-Dastgerdi, Hajaralsadat, et al.
Publicado: (2022)

Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes
por: Wang, Shuya, et al.
Publicado: (2016)

Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes
por: Wang, Shuya, et al.
Publicado: (2020)

GMP Synthetase: Allostery, Structure, and Function
por: Ballut, Lionel, et al.
Publicado: (2023)

NMR Methods to Study Dynamic Allostery
por: Grutsch, Sarina, et al.
Publicado: (2016)

Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies
por: Civieri, Giovanni, et al.
Publicado: (2022)

Decoding the mechanisms of allostery
por: Khan, Saif, et al.
Publicado: (2023)

The Angiotensin II Type 2 Receptor in Brain Functions: An Update
por: Guimond, Marie-Odile, et al.
Publicado: (2012)

Ack1: Activation and Regulation by Allostery
por: Gajiwala, Ketan S., et al.
Publicado: (2013)

Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors
por: Do, Hung, et al.
Publicado: (2023)

Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors
por: Do, Hung N., et al.
Publicado: (2023)

Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors
por: Do, Hung N., et al.
Publicado: (2023)

Rational Drug Design and Synthesis of Molecules Targeting the Angiotensin II Type 1 and Type 2 Receptors
por: Kellici, Tahsin F., et al.
Publicado: (2015)

Cytokine Profiles Associated With Angiotensin II Type 1 Receptor Antibodies
por: Pearl, Meghan H., et al.
Publicado: (2018)

Convergent allostery in ribonucleotide reductase
por: Thomas, William C., et al.
Publicado: (2019)

Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism
por: Meyer, Lucie S., et al.
Publicado: (2020)

Angiotensin II Stimulates the Proliferation and Migration of Lymphatic Endothelial Cells Through Angiotensin Type 1 Receptors
por: Lin, Qiu-Yue, et al.
Publicado: (2020)

AlphaFold, Artificial Intelligence (AI), and Allostery
por: Nussinov, Ruth, et al.
Publicado: (2022)

Interaction of Angiotensin II AT1 Receptors with Purinergic P2X Receptors in Regulating Renal Afferent Arterioles in Angiotensin II-Dependent Hypertension
por: Kulthinee, Supaporn, et al.
Publicado: (2023)

Increased AT(2)R expression is induced by AT(1)R autoantibody via two axes, Klf-5/IRF-1 and circErbB4/miR-29a-5p, to promote VSMC migration
por: Sun, Yan, et al.
Publicado: (2020)

Angiotensin Converting Enzyme and Angiotensin II Type 1 Receptor Polymorphisms in Patients with Coronary Aneurysms
por: Lamblin, Nicolas, et al.
Publicado: (2003)

Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor
por: Cha, Seung Ah, et al.
Publicado: (2018)

MON-538 Ca(2+)Allostery in PTH-Receptor Signaling
por: White, Alex, et al.
Publicado: (2019)

Angiotensin II modulates THP-1-like macrophage phenotype and inflammatory signatures via angiotensin II type 1 receptor
por: Barhoumi, Tlili, et al.
Publicado: (2023)

Enhancement of Adipocyte Browning by Angiotensin II Type 1 Receptor Blockade
por: Tsukuda, Kana, et al.
Publicado: (2016)

Virus assembly, allostery and antivirals
por: Zlotnick, Adam, et al.
Publicado: (2011)

Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
por: Vasile, Silvana, et al.
Publicado: (2020)

Effects of moderate-intensity endurance exercise on angiotensin II and angiotensin II type I receptors in the rat heart
por: Li, Xin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ps324o09bk477lhvd5k77b59si